Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jan J.B. Boesen"'
Autor:
Patrick Hundsdörfer, Raimund Höft, D. A. Breems, W. Jens Zeller, Stefan Fruehauf, Bob Löwenberg, Dinko Valerio, Rainer Haas, Jan J.B. Boesen, Rob E. Ploemacher
Publikováno v:
Stem Cells. 13:93-99
Transfer of the multidrug resistance-1 (MDR1) gene to hemopoietic cells for myeloprotection against cytostatic agents is a new and rapidly developing field in "cancer gene therapy." Before clinical application, safety and efficacy criteria need to be
Publikováno v:
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 307:121-129
The Luria-Delbruck fluctuation analysis provides a method to estimate mutation rates and is commonly applied in somatic cell genetics and in cancer biology. We developed an assay for a Luria-Delbruck fluctuation analysis using the mouse lymphoma cell
Publikováno v:
Biotherapy (Dordrecht, Netherlands). 6(4)
Drug-induced myelosuppression is a frequent reason for curtailing chemotherapy in cancer patients. 'Rescue' of myelosuppressed patients with autologous marrow transplants is reasonably advanced and permits an increase in the dose of anticancer drugs.
Publikováno v:
Carcinogenesis. 13(12)
Ultraviolet irradiation triggers a response in mammalian cells known as the UV response. Part of the UV response forms the enhanced synthesis of various extracellular proteins able to transmit the response to non-irradiated cells. Because several can
Autor:
J.W.I.M. Simons, Sandrine Stuivenberg, Jan J.B. Boesen, Paul H.M. Lohman, Henk Panneman, Corné H. M. Thyssens, Firouz Darroudi
Publikováno v:
Moleculargeneral genetics : MGG. 234(2)
Cells of the mouse T-lymphoma line GRSL13 were treated with 8-methoxy-psoralen plus longwave ultraviolet light (PUVA) under conditions where the biological effects are mainly due to non-persistent DNA cross-links (PUVA-CL treatment). Fluctuation anal
Publikováno v:
Carcinogenesis. 12(3)
The hypothesis that activation of the signal transduction pathways by environmental stress may lead to genetic instability was tested. Mouse T-lymphoma cells, GRSL13, were treated with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Th